See the DrugPatentWatch profile for lipitor
Lipitor, also known as atorvastatin, is a medication used to lower cholesterol levels in the blood [1]. However, one of the side effects of Lipitor is muscle pain or weakness, which can be prevented through exercise. According to Mayo Clinic, regular exercise can help prevent muscle pain and weakness caused by statins like Lipitor [2]. The National Center for Biotechnology Information (NCBI) recommends that individuals who experience muscle pain while taking statins should engage in regular physical activity, such as aerobic exercise, resistance training, and stretching, to reduce the risk of muscle-related side effects [3].
The frequency of exercise needed to prevent Lipitor muscle pain is not specified in the sources provided. However, it is generally recommended that adults engage in at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity aerobic exercise per week, in addition to muscle-strengthening activities at least two days per week [2]. It is important to consult with a healthcare provider before starting an exercise program, especially if you are experiencing muscle pain while taking Lipitor.
In summary, regular exercise can help prevent muscle pain and weakness caused by Lipitor. The recommended frequency of exercise is at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity aerobic exercise per week, in addition to muscle-strengthening activities at least two days per week. It is important to consult with a healthcare provider before starting an exercise program, especially if you are experiencing muscle pain while taking Lipitor.
Sources:
[1] DrugPatentWatch. Lipitor.
https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] Mayo Clinic. Statin side effects: Weigh the benefits and risks.
https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013
[3] National Center for Biotechnology Information. Statin-Associated Muscle Symptoms: Impact on Statin Therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463373/